✦ LIBER ✦

A phase III, multicenter, randomized study comparing ustekinumab and etanercept for the treatment of moderate to severe plaque psoriasis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-efficacy of adalimumab, etanercept,

✍ C. Ferrándiz; A. García; A.J. Blasco; P. Lázaro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

PSY27 Cost Effectiveness of Treatment Wi

✍ R. Villacorta; J. Hay; A. Messali 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost Utility Analysis Based on a Head-to

✍ Feng Pan; Nicole C. Brazier; Neil H. Shear; Farah Jivraj; Brad Schenkel; Ruth Br 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Pooled safety and efficacy results from

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and safety of ustekinumab for t

✍ Tsai, Tsen-Fang; Ho, Ji-Chen; Song, Michael; Szapary, Philippe; Guzzo, Cynthia; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 442 KB

Efficacy and safety results from a phase

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB